Kailera Therapeutics (KLRA) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Phibro Animal Health is the larger company by market cap ($1.56 billion vs $1.51 billion), about 1.0 times the size. Phibro Animal Health pays a dividend yielding 1.25%, while Kailera Therapeutics does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KLRA | PAHC |
|---|---|---|
| Share price | $11.61 | $38.30 |
| Market cap | $1.51B | $1.56B |
| 1-day change | +16.10% | +2.41% |
| YTD return | — | +2.52% |
| 1-year return | — | +3.04% |
| 5-year return | — | +75.69% |
| P/E ratio (TTM) | — | 15.76 |
| Forward P/E | — | 9.97 |
| EPS (TTM) | $-4.51 | $2.43 |
| Dividend yield | 0.00% | 1.25% |
| Annual dividend | $0.00 | $0.48 |
| Revenue (latest FY) | — | $1.52B |
| Revenue growth (YoY) | — | +17.12% |
| Net income (latest FY) | — | $99.72M |
| Gross margin | — | 33.76% |
| Operating margin | — | 12.81% |
| Net margin | — | 6.57% |
| 52-week high | $28.23 | $60.08 |
| 52-week low | $9.76 | $28.25 |
| Distance from 52-week high | -58.87% | -36.25% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | +265.20% | +14.88% |
| Average volume | 886.37K | 231.66K |
| Shares outstanding | 129.64M | 21.11M |
| Employees | 145 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Phibro Animal Health offers a meaningfully higher dividend yield (1.25% vs 0.00%).
About Kailera Therapeutics
KLRA stock →Kailera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company developing therapies for obesity and related conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
KLRA vs PAHC FAQ
Which is bigger, Kailera Therapeutics or Phibro Animal Health?
Phibro Animal Health (PAHC) is larger, with a market capitalization of $1.56B compared with $1.51B for Kailera Therapeutics (KLRA).
Which pays a higher dividend, Kailera Therapeutics or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.25%, while Kailera Therapeutics does not currently pay a regular dividend.
Are Kailera Therapeutics and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.